These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22162909)

  • 1. Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans.
    Bogaard HJ; Mizuno S; Guignabert C; Al Hussaini AA; Farkas D; Ruiter G; Kraskauskas D; Fadel E; Allegood JC; Humbert M; Vonk Noordegraaf A; Spiegel S; Farkas L; Voelkel NF
    Am J Respir Cell Mol Biol; 2012 May; 46(5):582-91. PubMed ID: 22162909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
    Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
    FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.
    Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
    Eur J Pharmacol; 2017 Sep; 810():83-91. PubMed ID: 28576407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-Lipoxygenase and 12-hydroxyeicosatetraenoic acid regulate hypoxic angiogenesis and survival of pulmonary artery endothelial cells via PI3K/Akt pathway.
    Zhang C; Ma C; Yao H; Zhang L; Yu X; Liu Y; Shen T; Zhang L; Zhang F; Chen X; Zhu D
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L606-L616. PubMed ID: 29074487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
    Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.
    Al Husseini A; Bagnato G; Farkas L; Gomez-Arroyo J; Farkas D; Mizuno S; Kraskauskas D; Abbate A; Van Tassel B; Voelkel NF; Bogaard HJ
    Eur Respir J; 2013 Jan; 41(1):104-14. PubMed ID: 22835607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.
    Taraseviciene-Stewart L; Scerbavicius R; Choe KH; Cool C; Wood K; Tuder RM; Burns N; Kasper M; Voelkel NF
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L668-76. PubMed ID: 16698853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
    Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
    Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
    Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
    Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
    Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation.
    Zuckerbraun BS; Shiva S; Ifedigbo E; Mathier MA; Mollen KP; Rao J; Bauer PM; Choi JJ; Curtis E; Choi AM; Gladwin MT
    Circulation; 2010 Jan; 121(1):98-109. PubMed ID: 20026772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.
    Sands M; Howell K; Costello CM; McLoughlin P
    Respir Res; 2011 Jan; 12(1):17. PubMed ID: 21266048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells.
    Yu X; Chen X; Zheng XD; Zhang J; Zhao X; Liu Y; Zhang H; Zhang L; Yu H; Zhang M; Ma C; Hao X; Zhu D
    Hypertension; 2018 Apr; 71(4):729-741. PubMed ID: 29463625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
    Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
    Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.
    Klinger JR; Pereira M; Del Tatto M; Brodsky AS; Wu KQ; Dooner MS; Borgovan T; Wen S; Goldberg LR; Aliotta JM; Ventetuolo CE; Quesenberry PJ; Liang OD
    Am J Respir Cell Mol Biol; 2020 May; 62(5):577-587. PubMed ID: 31721618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.